Biotech Archives - Page 23 of 795

1 minute read

AbbVie Presents Tumor Pipeline At ASCO 2024 With New Data From Its Innovative Antibody-Drug Conjugate Platform

May 28, 8:03 AM

New safety and efficacy data in heavily pre-treated patients with metastatic colorectal cancer (CRC), from a Phase 1 study of ABBV-400, a next-generation, potential best-in-class c-Met directed ADC.Data from a

ABBV

2 minute read

EXCLUSIVE: Vivani Medical Highlights Weight Loss Data For GLP-1 Implant Supporting Potential Veterinary Use

By Vandana Singh

May 28, 7:30 AM

Vivani Medical announced proof-of-concept data for a subdermal exenatide implant designed for feline obesity and diabetes, which was published in BMC Veterinary Research.

VANI

2 minute read

‘Not Just A Weight Loss Story:’ Eli Lilly CEO Thinks It’s Possible To Meet BofA’s $60B Revenue Projection From New Drug Launches

By Benzinga Neuro

May 28, 2:38 AM

Ricks highlighted that the company is trying to prove the efficacy of its drugs for not only weight loss but also obesity-driven diseases such as heart risks, diabetes, and sleep apnea.

LLY

4 minute read

EXCLUSIVE: Coya Therapeutics, Focused On Neurodegenerative Diseases Has Gained 70% Since IPO; CEO Highlights Efforts On Combination Therapy For Rare Diseases

By Vandana Singh

May 27, 9:43 AM

Coya Therapeutics is working On neurodegenerative disease treatment with its combination therapies targeting regulatory T cells. CEO Howard Berman discusses the potential of COYA 302 for ALS, FTD, Parkinson's, and Alzheimer's, emphasizing a transformative approach to immune balance restoration.

BBIB

2 minute read

AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report

By Benzinga Neuro

May 27, 7:12 AM

Western pharmaceutical companies and investors are driving a record number of licensing deals with Chinese drugmakers.

AZN

2 minute read

Eli Lilly Makes Largest Manufacturing Investment In Its History To Boost Production For Antidiabetic And Weight Loss Meds

By Vandana Singh

May 24, 2:03 PM

Eli Lilly has significantly increased its investment in its Lebanon, Indiana, manufacturing site to $9 billion, aiming to enhance production of tirzepatide injections.

LLY

2 minute read

Zantac Verdict: Jury Finds No Link To Colon Cancer In Initial Trial, GSK And Boehringer Prevail In First Zantac Cancer Lawsuit

By Vandana Singh

May 24, 1:45 PM

Chicago jury rejects woman's claim that Zantac caused her colon cancer. First of thousands of similar lawsuits, companies deny scientific evidence.

GSK

2 minute read

Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?

By Vandana Singh

May 24, 1:41 PM

Merus announces interim clinical data on petosemtamab and Keytruda (pembrolizumab) for first-line recurrent/metastatic head and neck squamous cell carcinoma. Early results show promising efficacy with a 60% response rate.

MRK